SDIX announces multi-year collaboration with Banyan Biomarkers

SDIX™ (Strategic Diagnostics Inc. d/b/a SDIX, NASDAQ: SDIX), today announced a multi-year collaboration with Banyan Biomarkers, Inc. to provide products and services for Banyan's biomarker discovery work in the detection of traumatic brain injury (TBI).

“We look forward to working with SDIX on the development of antibodies and immuno-solutions”

The partnership calls for SDIX to collaborate with Banyan on the development of antibodies and immuno-solutions that include:

  • custom monoclonal and polyclonal antibody development
  • cell line banking and cryostorage
  • antibody production and purification - in vivo and in vitro

Dr. Walid Qoronfleh, SDIX Executive Director, Life Sciences, said, "We look forward to working with Banyan Biomarkers as they continue their breakthrough work addressing the unmet clinical needs for detecting TBI. We believe our twenty years of experience in providing immuno-solutions; from antibody to assay development, as well as our in vitro diagnostics expertise make SDIX a valuable partner for companies like Banyan."

Mr. Fran DiNuzzo, SDIX President and CEO said, "We appreciate the opportunity to collaborate on this critical biomarker project with Banyan to help save and improve the lives of patients with brain injuries, including the potential of helping the brave men and women serving in our armed forces."

"We look forward to working with SDIX on the development of antibodies and immuno-solutions," stated Jackson Streeter, MD, CEO of Banyan Biomarkers. "This is an important step in the discovery of diagnostics and treatments for TBI and other neurological disorders."

According to the Centers for Disease Control (CDC), at least 1.7 million suffer a traumatic brain injury (TBI) in the United States annually. That's more than the number diagnosed with the top five cancers combined according to National Cancer Institute (NCI) statistics. Of those individuals, about 52,000 die, 275,000 are hospitalized, and 1.365 million are treated and released from an emergency department. The International Brain Injury Association ( reports 5.3 million Americans are living today with disabilities related to TBI.




The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Powerful injectable gel provides hope for preventing glioblastoma relapse